Works matching IS 09395555 AND DT 2011 AND VI 90


Results: 244
    1
    2
    3
    4

    Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with I-anti-CD20 antibody and stem cell rescue.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 11, p. 1307, doi. 10.1007/s00277-011-1199-y
    By:
    • Hohloch, Karin;
    • Sahlmann, Carsten;
    • Lakhani, Vijai;
    • Wulf, Gerald;
    • Glaß, Bertram;
    • Hasenkamp, Justin;
    • Meller, Johannes;
    • Riggert, Joachim;
    • Trümper, Lorenz;
    • Griesinger, Frank
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 12, p. 1419, doi. 10.1007/s00277-011-1219-y
    By:
    • Yang, Deok-Hwan;
    • Kim, Mi-Hyun;
    • Lee, Youn-Kyung;
    • Hong, Cheol;
    • Lee, Hyun;
    • Nguyen-Pham, Thanh-Nhan;
    • Bae, Soo;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Chung, Ik-Joo;
    • Kim, Hyeoung-Joon;
    • Kalinski, Pawel;
    • Lee, Je-Jung
    Publication type:
    Article
    18
    19

    Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 12, p. 1427, doi. 10.1007/s00277-011-1224-1
    By:
    • Verelst, Silvia;
    • Termorshuizen, F.;
    • Uyl-de Groot, C.;
    • Schaafsma, M.;
    • Ammerlaan, A.;
    • Wittebol, S.;
    • Sinnige, H.;
    • Zweegman, S.;
    • Marwijk Kooy, M.;
    • Griend, R.;
    • Lokhorst, H.;
    • Sonneveld, P.;
    • Wijermans, P.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    28
    29
    30
    31
    32
    33

    Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 11, p. 1255, doi. 10.1007/s00277-011-1195-2
    By:
    • Huh, Jungwon;
    • Jung, Chul;
    • Kim, Jong;
    • Kim, Hee-Jin;
    • Kim, Sun-Hee;
    • Shin, Myung;
    • Kim, Yeo;
    • Joon Kim, Hyeoung;
    • Suh, Jang;
    • Moon, Joon;
    • Sohn, Sang;
    • Nam, Goong;
    • Lee, Jong-eun;
    • Kim, Dong
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 10, p. 1131, doi. 10.1007/s00277-011-1260-x
    By:
    • Gruber, Michaela;
    • Fleiss, Karin;
    • Porpaczy, Edit;
    • Skrabs, Cathrin;
    • Hauswirth, Alexander W.;
    • Gaiger, Alexander;
    • Vanura, Katrina;
    • Heintel, Daniel;
    • Shehata, Medhat;
    • Einberger, Christine;
    • Thalhammer, Renate;
    • Fonatsch, Christa;
    • Jäger, Ulrich
    Publication type:
    Article
    50